Big buyers target scale across media, biotech and travel

Summary

Vertex will pay $10 billion to acquire Crinetics Pharmaceuticals, adding Crinetics' drug for a rare endocrine disorder to its portfolio. The deal extends a wave of large-cap biotech acquisitions aimed at buying late-stage or de-risked assets.

Why it matters

A $10 billion biotech takeout reinforces a higher clearing price for late-stage rare-disease assets and signals more consolidation ahead.

Summary

The July 4 weekend box office underperformed expectations, with Universal and Illumination’s “Minions and Monsters” posting a soft U.S. debut while Angel Studios’ indie “Young Washington” delivered a stronger-than-expected turnout. Comcast-owned Sky agreed to buy U.K. broadcaster ITV as it looks to scale up content and distribution in a tougher TV ad and streaming market.

Why it matters

A weaker tentpole box office and a major U.K. TV tie-up both point to an industry reallocating power toward scaled distribution and efficient, targeted hits.

Summary

Sky agreed a £1.6bn deal to acquire ITV, consolidating two major UK broadcasters. The combination would leave Comcast in control of a broadcaster reaching about 21 million households.

Why it matters

It rewires UK media market power, shaping who controls audience reach, ad inventory, and domestic content investment.

Summary

EasyJet’s board said it has an outline agreement with Castlelake on a roughly £5 billion all cash takeover and is minded to recommend the deal. The proposal comes from the US private credit group after multiple prior approaches.

Why it matters

A successful take-private would reset the valuation benchmark for European airlines and show how private credit can drive large cap M&A in public markets.